Peregrine to Report Financial Results for Second Quarter of Fiscal Year 2016 After Market Close on December 10, 2015
December 03 2015 - 4:05PM
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a
biopharmaceutical company focused on developing therapeutics to
stimulate the body's immune system to fight cancer, today announced
that it will report financial results for the second quarter of
fiscal year 2016 ended October 31, 2015 on December 10, 2015 after
market and will host a conference call and webcast at 1:30 PM
Pacific Time (4:30 PM Eastern Time). Peregrine's senior management
will discuss financial results for the second quarter and review
the recent progress of its clinical development programs.
To listen to the live webcast, or access the
archived webcast, please visit:
http://ir.peregrineinc.com/events.cfm.
To listen to the conference call, please dial
(877) 312-5443 or (253) 237-1126 and request the Peregrine
Pharmaceuticals call.
About Peregrine Pharmaceuticals,
Inc.Peregrine Pharmaceuticals, Inc. is a biopharmaceutical
company with a pipeline of novel drug candidates in clinical trials
focused on the treatment of cancer. The company's lead
immunotherapy candidate, bavituximab, is in Phase III development
for the treatment of previously treated non-small cell lung cancer
(the "SUNRISE trial") along with several investigator-sponsored
trials evaluating other treatment combinations and additional
oncology indications. Peregrine also has in-house cGMP
manufacturing capabilities through its wholly-owned subsidiary Avid
Bioservices, Inc. (www.avidbio.com), which provides development and
biomanufacturing services for both Peregrine and third-party
customers. For more information, please visit
www.peregrineinc.com.
Contacts:
Jay Carlson
Peregrine Pharmaceuticals, Inc.
(800) 987-8256
info@peregrineinc.com
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Sep 2023 to Sep 2024